Health and Healthcare

Merck : MRK

All Merck Articles

1084 Articles

Chris Lange | Mar 27, 2017 at 8:35 AM EDT

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

The March 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Mar 25, 2017 at 9:15 AM EDT

How Health Care Stocks Responded to the Shelved Health Care Bill

24/7 Wall St. has taken a look at a few companies within the health care sector that might have seen…

Paul Ausick | Mar 16, 2017 at 4:05 PM EDT

DuPont, Chevron Take DJIA Down Thursday

DuPont, Chevron, Merck, and Pfizer sink the DJIA on Thursday.

Paul Ausick | Mar 13, 2017 at 4:01 PM EDT

Intel, GE Weigh on DJIA Monday

Intel, GE, Merck, and Chevron weighed on the DJIA Monday.

Chris Lange | Mar 10, 2017 at 8:55 AM EST

Short Sellers Back Off Major Pharma

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | Mar 7, 2017 at 4:01 PM EST

Chevron, Verizon Sink DJIA on Tuesday

Chevron, Verizon, Pfizer, and Merck combined to weigh on the DJIA Tuesday.

Chris Lange | Mar 6, 2017 at 9:50 AM EST

Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here

Merck and Pfizer each saw their shares sink early on Monday after the firms gave an update on their type…

Chris Lange | Feb 28, 2017 at 8:55 AM EST

Why Short Sellers Are Making a Massive Bet in Major Pharma

Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.

Chris Lange | Feb 15, 2017 at 12:10 PM EST

Merck Delivers Even More Disappointing News in Alzheimer’s Study

Merck saw its shares slip on Wednesday after the firm reported that it will be halting its mid-to-late-stage clinical trial…

Paul Ausick | Feb 14, 2017 at 4:01 PM EST

Apple, JPMorgan Dominate DJIA on Tuesday

JPMorgan, Apple, Merck, and Goldman Sachs all set new 52-week highs and dominated the rising DJIA on Tuesday.

Chris Lange | Feb 10, 2017 at 8:35 AM EST

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far…

Chris Lange | Feb 2, 2017 at 9:05 AM EST

Why Merck’s Q4 Earnings Aren’t Enough for Investors

Merck reported disappointing fourth-quarter financial results before the markets opened on Thursday.

Chris Lange | Feb 1, 2017 at 12:05 PM EST

The Top 2 Dow Stocks Reporting on Thursday

24/7 Wall St. has put together a preview of the two Dow stocks scheduled to report their quarterly results on…

Chris Lange | Jan 29, 2017 at 10:25 AM EST

What to Expect From Dow Stocks Reporting This Week

Five of the Dow stocks are reporting next week, and this has the potential to sustain the run that the…

Chris Lange | Jan 26, 2017 at 9:50 AM EST

Short Sellers Run for Cover From Major Pharma

The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

1 … 30 31 32 33 34 … 73

Merck : MRK

All Merck Articles

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

How Health Care Stocks Responded to the Shelved Health Care Bill

DuPont, Chevron Take DJIA Down Thursday

Intel, GE Weigh on DJIA Monday

Short Sellers Back Off Major Pharma

Chevron, Verizon Sink DJIA on Tuesday

Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here

Why Short Sellers Are Making a Massive Bet in Major Pharma

Merck Delivers Even More Disappointing News in Alzheimer’s Study

Apple, JPMorgan Dominate DJIA on Tuesday

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

Why Merck’s Q4 Earnings Aren’t Enough for Investors

The Top 2 Dow Stocks Reporting on Thursday

What to Expect From Dow Stocks Reporting This Week

Short Sellers Run for Cover From Major Pharma

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Merck : MRK

All Merck Articles

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

How Health Care Stocks Responded to the Shelved Health Care Bill

DuPont, Chevron Take DJIA Down Thursday

Intel, GE Weigh on DJIA Monday

Short Sellers Back Off Major Pharma

Chevron, Verizon Sink DJIA on Tuesday

Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here

Why Short Sellers Are Making a Massive Bet in Major Pharma

Merck Delivers Even More Disappointing News in Alzheimer’s Study

Apple, JPMorgan Dominate DJIA on Tuesday

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

Why Merck’s Q4 Earnings Aren’t Enough for Investors

The Top 2 Dow Stocks Reporting on Thursday

What to Expect From Dow Stocks Reporting This Week

Short Sellers Run for Cover From Major Pharma

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Featured Reads

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It